{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:43:19Z","timestamp":1785300199144,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10067-022-06108-z","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T15:21:59Z","timestamp":1645456919000},"page":"1911-1918","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development of severe colitis in Takayasu arteritis treated with tocilizumab"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-7451","authenticated-orcid":false,"given":"Kae","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6295-3494","authenticated-orcid":false,"given":"Tsuyoshi","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7042-009X","authenticated-orcid":false,"given":"Yoichi","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2160-4116","authenticated-orcid":false,"given":"Tomoaki","family":"Machiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7139-7792","authenticated-orcid":false,"given":"Hiroko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5361-5824","authenticated-orcid":false,"given":"Tomonori","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-7442","authenticated-orcid":false,"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-6492","authenticated-orcid":false,"given":"Hiroshi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"6108_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3899\/jrheum.181219","volume":"47","author":"T Mutoh","year":"2020","unstructured":"Mutoh T, Shirai T, Fujii H, Ishii T, Harigae H (2020) Insufficient use of corticosteroids without immunosuppressants results in higher relapse rates in Takayasu arteritis. J Rheumatol 47:255\u2013263. https:\/\/doi.org\/10.3899\/jrheum.181219","journal-title":"J Rheumatol"},{"key":"6108_CR2","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/art.41774","volume":"73","author":"M Maz","year":"2021","unstructured":"Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Imundo LF, Kim S, Merkel PA, Rhee RL, Seo P, Stone JH, Sule S, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot MA, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA (2021) 2021 American college of rheumatology\/vasculitis foundation guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Rheumatol 73:1349\u20131365. https:\/\/doi.org\/10.1002\/art.41774","journal-title":"Arthritis Rheumatol"},{"key":"6108_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","volume":"79","author":"B Hellmich","year":"2020","unstructured":"Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, Hatemi G, Hollinger N, Mahr A, Mollan SP, Mukhtyar C, Ponte C, Salvarani C, Sivakumar R, Tian X, Tomasson G, Turesson C, Schmidt W, Villiger PM, Watts R, Young C, Luqmani RA (2020) 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 79:19\u201330. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215672","journal-title":"Ann Rheum Dis"},{"key":"6108_CR4","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1007\/s10067-021-05743-2","volume":"40","author":"DP Misra","year":"2021","unstructured":"Misra DP, Rathore U, Patro P, Agarwal V, Sharma A (2021) Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis-a systematic review and meta-analysis. Clin Rheumatol 40:4391\u20134416. https:\/\/doi.org\/10.1007\/s10067-021-05743-2","journal-title":"Clin Rheumatol"},{"key":"6108_CR5","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1093\/rheumatology\/kez630","volume":"59","author":"Y Nakaoka","year":"2020","unstructured":"Nakaoka Y, Isobe M, Tanaka Y, Ishii T, Ooka S, Niiro H, Tamura N, Banno S, Yoshifuji H, Sakata Y, Kawakami A, Atsumi T, Furuta S, Kohsaka H, Suzuki K, Hara R, Maejima Y, Tsukamoto H, Takasaki Y, Yamashita K, Okada N, Yamakido S, Takei S, Yokota S, Nishimoto N (2020) Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study. Rheumatology (Oxford) 59:2427\u20132434. https:\/\/doi.org\/10.1093\/rheumatology\/kez630","journal-title":"Rheumatology (Oxford)"},{"key":"6108_CR6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/annrheumdis-2017-211878","volume":"77","author":"Y Nakaoka","year":"2018","unstructured":"Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N (2018) Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis 77:348\u2013354. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211878","journal-title":"Ann Rheum Dis"},{"key":"6108_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13075-020-02311-y","volume":"22","author":"A Mekinian","year":"2020","unstructured":"Mekinian A, Saadoun D, Vicaut E, Thietart S, Lioger B, Jego P, Bleibtreu A, Limal N, Connault J, Gottenberg JE, Lhorte P, Bertola JP, Delforge J, Ferreira-Maldent N, Perlat A, Talib Z, Vautier M, Savey L, Quiere I, Cacoub P, Fain O, Network FT (2020) Tocilizumab in treatment-naive patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial. Arthritis Res Ther 22:218. https:\/\/doi.org\/10.1186\/s13075-020-02311-y","journal-title":"Arthritis Res Ther"},{"key":"6108_CR8","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/rheumatology\/kez511","volume":"59","author":"S Saito","year":"2020","unstructured":"Saito S, Okuyama A, Okada Y, Shibata A, Sakai R, Kurasawa T, Kondo T, Takei H, Amano K (2020) Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study. Rheumatology (Oxford) 59:1617\u20131621. https:\/\/doi.org\/10.1093\/rheumatology\/kez511","journal-title":"Rheumatology (Oxford)"},{"key":"6108_CR9","doi-asserted-by":"publisher","unstructured":"Prieto-Pena D, Calderon-Goercke M, Bernabeu P, Vela-Casasempere P, Narvaez J, Fernandez-Lopez C, Gonzalez MF, Gonzalez-Alvarez B, Solans-Laque R, Callejas-Rubio JL, Ortego N, Fernandez-Diaz C, Romero ER, Morillo SG, Minguez M, Fernandez-Carballido C, De Miguel E, Melchor S, Salgado-Perez E, Bravo B, Romero-Yuste S, Salvatierra J, Hidalgo C, Arija SM, Romero-Gomez C, Moya P, Alvarez-Rivas N, Mendizabal J, Sanjuan FMO, de Pedro IP, Loricera J, Castaneda S, Gonzalez-Gay MA, Blanco R (2021) Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and lit. Ther Adv Musculoskelet Dis 13:1759720X211020917. https:\/\/doi.org\/10.1177\/1759720X211020917","DOI":"10.1177\/1759720X211020917"},{"key":"6108_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/03009742.2021.1881155","volume":"50","author":"T Shirai","year":"2021","unstructured":"Shirai T, Sato H, Fujii H, Ishii T, Harigae H (2021) The feasible maintenance dose of corticosteroid in Takayasu arteritis in the era of biologic therapy. Scand J Rheumatol 50:462\u2013468. https:\/\/doi.org\/10.1080\/03009742.2021.1881155","journal-title":"Scand J Rheumatol"},{"key":"6108_CR11","doi-asserted-by":"publisher","unstructured":"Rempenault C, Lukas C, Combe B, Herrero A, Pane I, Schaeverbeke T, Wendling D, Pham T, Gottenberg JE, Mariette X, Morel J, French Society of R, the investigators participating in Air-Pr ORA, registries R (2021) Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept. Rheumatology (Oxford) keab438. https:\/\/doi.org\/10.1093\/rheumatology\/keab438","DOI":"10.1093\/rheumatology\/keab438"},{"key":"6108_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1253\/circj.cj-88-0007","volume":"75","author":"Group JCSJW","year":"2011","unstructured":"Group JCSJW (2011) Guideline for management of vasculitis syndrome (JCS 2008). Circ J 75:474\u2013503. https:\/\/doi.org\/10.1253\/circj.cj-88-0007","journal-title":"Circ J"},{"key":"6108_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/art.1780330811","volume":"33","author":"WP Arend","year":"1990","unstructured":"Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129\u20131134. https:\/\/doi.org\/10.1002\/art.1780330811","journal-title":"Arthritis Rheum"},{"key":"6108_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3899\/jrheum.130466","volume":"41","author":"T Koike","year":"2014","unstructured":"Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Takei S, Tanaka Y, Sano Y, Yaguramaki H, Yamanaka H (2014) Effectiveness and safety of tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan. J Rheumatol 41:15\u201323. https:\/\/doi.org\/10.3899\/jrheum.130466","journal-title":"J Rheumatol"},{"key":"6108_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4049\/jimmunol.1600960","volume":"199","author":"V Jeffery","year":"2017","unstructured":"Jeffery V, Goldson AJ, Dainty JR, Chieppa M, Sobolewski A (2017) IL-6 signaling regulates small intestinal crypt homeostasis. J Immunol 199:304\u2013311. https:\/\/doi.org\/10.4049\/jimmunol.1600960","journal-title":"J Immunol"},{"key":"6108_CR16","doi-asserted-by":"publisher","first-page":"e114195","DOI":"10.1371\/journal.pone.0114195","volume":"9","author":"KA Kuhn","year":"2014","unstructured":"Kuhn KA, Manieri NA, Liu TC, Stappenbeck TS (2014) IL-6 stimulates intestinal epithelial proliferation and repair after injury. PLoS ONE 9:e114195. https:\/\/doi.org\/10.1371\/journal.pone.0114195","journal-title":"PLoS ONE"},{"key":"6108_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/gut.2008.151175","volume":"59","author":"X Jin","year":"2010","unstructured":"Jin X, Zimmers TA, Zhang Z, Pierce RH, Koniaris LG (2010) Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut 59:186\u2013196. https:\/\/doi.org\/10.1136\/gut.2008.151175","journal-title":"Gut"},{"key":"6108_CR18","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s10620-013-2656-3","volume":"58","author":"L Zhang","year":"2013","unstructured":"Zhang L, Hu L, Chen M, Yu B (2013) Exogenous interleukin-6 facilitated the contraction of the colon in a depression rat model. Dig Dis Sci 58:2187\u20132196. https:\/\/doi.org\/10.1007\/s10620-013-2656-3","journal-title":"Dig Dis Sci"},{"issue":"46\u201359","key":"6108_CR19","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.stem.2018.05.002","volume":"23","author":"S Yu","year":"2018","unstructured":"Yu S, Tong K, Zhao Y, Balasubramanian I, Yap GS, Ferraris RP, Bonder EM, Verzi MP, Gao N (2018) Paneth cell multipotency induced by notch activation following Injury. Cell Stem Cell 23(46\u201359):e5. https:\/\/doi.org\/10.1016\/j.stem.2018.05.002","journal-title":"Cell Stem Cell"},{"key":"6108_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.imlet.2011.09.001","volume":"141","author":"M Hashiguchi","year":"2011","unstructured":"Hashiguchi M, Hachimura S, Ametani A, Sato T, Kojima H, Kumagai Y, Habu S, Kobata T, Kaminogawa S (2011) Naive CD4+ T cells of Peyer\u2019s patches produce more IL-6 than those of spleen in response to antigenic stimulation. Immunol Lett 141:109\u2013115. https:\/\/doi.org\/10.1016\/j.imlet.2011.09.001","journal-title":"Immunol Lett"},{"key":"6108_CR21","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2169\/internalmedicine.5215-20","volume":"60","author":"Y Hanioka","year":"2021","unstructured":"Hanioka Y, Shimizu K, Yamagami K, Yao S, Nakamura R, Nakamura T, Goto H (2021) Exacerbation of ulcerative colitis with tocilizumab: a report of two cases, one with Takayasu arteritis and the other with relapsing polychondritis. Intern Med 60:1615\u20131620. https:\/\/doi.org\/10.2169\/internalmedicine.5215-20","journal-title":"Intern Med"},{"key":"6108_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/14397595.2013.854045","volume":"24","author":"R Watanabe","year":"2014","unstructured":"Watanabe R, Ishii T, Nakamura K, Shirai T, Fujii H, Saito S, Harigae H (2014) Ulcerative colitis is not a rare complication of Takayasu arteritis. Mod Rheumatol 24:372\u2013373. https:\/\/doi.org\/10.3109\/14397595.2013.854045","journal-title":"Mod Rheumatol"},{"key":"6108_CR23","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/rheumatology\/keaa019","volume":"59","author":"T Shirai","year":"2020","unstructured":"Shirai T, Murakami K, Fujii H, Ishii T, Harigae H (2020) Comment on: aortarctia: a rare manifestation of relapsing polychondrits. Rheumatology (Oxford) 59:1784\u20131785. https:\/\/doi.org\/10.1093\/rheumatology\/keaa019","journal-title":"Rheumatology (Oxford)"},{"key":"6108_CR24","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2169\/internalmedicine.4331-19","volume":"59","author":"T Shirai","year":"2020","unstructured":"Shirai T, Komatsu H, Sato H, Fujii H, Ishii T, Harigae H (2020) Migratory aortitis associated with granulocyte-colony-stimulating factor. Intern Med 59:1559\u20131563. https:\/\/doi.org\/10.2169\/internalmedicine.4331-19","journal-title":"Intern Med"},{"key":"6108_CR25","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.2169\/internalmedicine.0329-17","volume":"57","author":"T Shirai","year":"2018","unstructured":"Shirai T, Hanaoka R, Goto Y, Kojima I, Ishii Y, Hoshi Y, Fujita Y, Shirota Y, Fujii H, Ishii T, Harigae H (2018) Takayasu arteritis coexisting with sclerosing osteomyelitis. Intern Med 57:1929\u20131934. https:\/\/doi.org\/10.2169\/internalmedicine.0329-17","journal-title":"Intern Med"},{"key":"6108_CR26","doi-asserted-by":"publisher","unstructured":"Ito N, Shirai T, Toyohara T, Hashimoto H, Sato H, Fujii H, Ishii T, Harigae H (2022) Coexistence of IgA nephropathy and renal artery stenosis in Takayasu arteritis: case report and literature review. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-021-05066-0","DOI":"10.1007\/s00296-021-05066-0"},{"key":"6108_CR27","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/art.39157","volume":"67","author":"C Terao","year":"2015","unstructured":"Terao C, Matsumura T, Yoshifuji H, Kirino Y, Maejima Y, Nakaoka Y, Takahashi M, Amiya E, Tamura N, Nakajima T, Origuchi T, Horita T, Matsukura M, Kochi Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Wada Y, Narita I, Kawaguchi Y, Yamanaka H, Ohmura K, Atsumi T, Tanemoto K, Miyata T, Kuwana M, Komuro I, Tabara Y, Ueda A, Isobe M, Mimori T, Matsuda F (2015) Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Arthritis Rheumatol 67:2226\u20132232. https:\/\/doi.org\/10.1002\/art.39157","journal-title":"Arthritis Rheumatol"},{"key":"6108_CR28","doi-asserted-by":"publisher","unstructured":"Kakuta Y, Shirai T, McGovern DPB, Braun J, Fujii H, Masamune A (2021) Novel diagnostic autoantibodies against endothelial protein C receptor in patients with ulcerative colitis. Clin Gastroenterol Hepatol;S1542\u20133565(21)01359\u20138. https:\/\/doi.org\/10.1016\/j.cgh.2021.12.035","DOI":"10.1016\/j.cgh.2021.12.035"},{"key":"6108_CR29","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/s41467-020-15088-0","volume":"11","author":"T Mutoh","year":"2020","unstructured":"Mutoh T, Shirai T, Ishii T, Shirota Y, Fujishima F, Takahashi F, Kakuta Y, Kanazawa Y, Masamune A, Saiki Y, Harigae H, Fujii H (2020) Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis. Nat Commun 11:1253. https:\/\/doi.org\/10.1038\/s41467-020-15088-0","journal-title":"Nat Commun"},{"key":"6108_CR30","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1053\/j.gastro.2021.03.037","volume":"161","author":"T Shirai","year":"2021","unstructured":"Shirai T, Kakuta Y, Fujii H (2021) Distinct autoantibodies against endothelial protein C receptor in ulcerative colitis. Gastroenterology 161:1724\u20131725. https:\/\/doi.org\/10.1053\/j.gastro.2021.03.037","journal-title":"Gastroenterology"},{"key":"6108_CR31","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/art.39037","volume":"67","author":"D Saadoun","year":"2015","unstructured":"Saadoun D, Garrido M, Comarmond C, Desbois AC, Domont F, Savey L, Terrier B, Geri G, Rosenzwajg M, Klatzmann D, Fourret P, Cluzel P, Chiche L, Gaudric J, Koskas F, Cacoub P (2015) Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheumatol 67:1353\u20131360. https:\/\/doi.org\/10.1002\/art.39037","journal-title":"Arthritis Rheumatol"},{"key":"6108_CR32","doi-asserted-by":"publisher","first-page":"7841718","DOI":"10.1155\/2016\/7841718","volume":"2016","author":"DP Misra","year":"2016","unstructured":"Misra DP, Chaurasia S, Misra R (2016) Increased Circulating Th17 Cells, Serum IL-17A, and IL-23 in Takayasu arteritis. Autoimmune Dis 2016:7841718. https:\/\/doi.org\/10.1155\/2016\/7841718","journal-title":"Autoimmune Dis"},{"key":"6108_CR33","doi-asserted-by":"publisher","first-page":"622934","DOI":"10.3389\/fimmu.2021.622934","volume":"12","author":"H Schmitt","year":"2021","unstructured":"Schmitt H, Neurath MF, Atreya R (2021) Role of the IL23\/IL17 pathway in Crohn\u2019s disease. Front Immunol 12:622934. https:\/\/doi.org\/10.3389\/fimmu.2021.622934","journal-title":"Front Immunol"},{"key":"6108_CR34","doi-asserted-by":"publisher","first-page":"611256","DOI":"10.3389\/fimmu.2021.611256","volume":"12","author":"D Noviello","year":"2021","unstructured":"Noviello D, Mager R, Roda G, Borroni RG, Fiorino G, Vetrano S (2021) The IL23-IL17 immune axis in the treatment of ulcerative colitis: successes, defeats, and ongoing challenges. Front Immunol 12:611256. https:\/\/doi.org\/10.3389\/fimmu.2021.611256","journal-title":"Front Immunol"},{"key":"6108_CR35","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/annrheumdis-2020-218719","volume":"79","author":"M Fauny","year":"2020","unstructured":"Fauny M, Moulin D, D\u2019Amico F, Netter P, Petitpain N, Arnone D, Jouzeau JY, Loeuille D, Peyrin-Biroulet L (2020) Paradoxical gastrointestinal effects of interleukin-17 blockers. Ann Rheum Dis 79:1132\u20131138. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218719","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06108-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06108-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06108-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T01:09:27Z","timestamp":1653008967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06108-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6108"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06108-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"26 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Written informed consents for publication of this case study and related clinical images were obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}